The CoreValve system, designed to replace a diseased aortic valve without open-heart surgery or surgical removal of the native valve, has now been implanted in more than 10,000 patients worldwide in 32 countries outside the US. Typically delivered through the femoral artery, CoreValve is used in...

According to the manufacturer, the system design includes a polyester cuff and bovine pericardial leaflets of a surgical heart valve with the deployment attributes of non-compliant PCI technology. The valve is delivered through a flexible 18F sheath. Do you have experience of using this...

This sheath is an excellent adjunct for EVAR procedures. It is comprised of an introducer sheath with a GORE DrySeal Sheath valve attached, a dilator, and a 2.5 ml valve inflation syringe. The valve is inflated around the device inserted through the sheath until haemostasis is achieved. It is...

The  Engager is delivered via a transapical catheter for the treatment of severe aortic stenosis in patients who are unsuitable for surgical valve replacement. The device has CE approval. The valve is composed of a nitinol frame and bovine tissue leaflets. CE clearance follows the...

Boston Scientific's Lotus transcatheter heart valve implant was awarded CE approval in October 2013. A ccording to the manufacturer, the product is the only aortic valve device that allows physicians to assess its final position before release. They say that it is designed to minimise the...